France· FR:69749137
VEYVONDI 1 300 UI poudre et solvant pour solution injectable
A vonicog alfa product containing vonicog alfa, registered in France by BAXALTA INNOVATIONS (AUTRICHE). The same ATC class is registered in 2 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Vonicog alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD40 (vonicog alfa), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 1 of them publish a price we can compare per daily dose
Vonicog alfa · ATC B02BD40
2 / 19 countries
- Franceprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- VONICOG ALFA
- Manufacturer
- BAXALTA INNOVATIONS (AUTRICHE)
- Country
- France (FR)
- ATC code
- B02BD40
- ATC class
- Vonicog alfa
- Defined daily dose
- 1.5 TSD, E
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550574441 flacon(s) en verre de 1300 UI - 1 flacon(s) de 10 ml avec dispositif(s) de reconstitution
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vonicog alfa in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenVEYVONDI 1300 IE Pulver och vätska till injektionsvätska, lösningBaxalta Innovations GmbH
- SwitzerlandVEYVONDI 1300 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungTakeda Pharma AG
- CzechiaVEYVONDIBaxalta Innovations GmbH, Vídeň
- FinlandVeyvondiBaxalta Innovations GmbH
- PolandVEYVONDIBaxalta Innovations GmbH
- BelgiumVeyvondi 1300 IUBaxalta Innovations
- United KingdomVeyvondi 1,300unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandVEYVONDI 1300 IU powder and solvent for solution for injectionBaxalta Innovations GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Veyvondi
- Liechtenstein · Veyvondi
- Norway · Veyvondi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4eb2f3d8-2ee3-40bf-b4b3-30d7db5ffde9 GET /v1/drugs/4eb2f3d8-2ee3-40bf-b4b3-30d7db5ffde9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69749137",
"date_amm": "2018-08-31",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/18/1298",
"substance": "VONICOG ALFA",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about vonicog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.